Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Coca-Cola Co K (KO) vs Moderna, Inc. (MRNA) Price & Performance

The Coca-Cola Co KTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

The Coca-Cola Co K vs Moderna, Inc. — how do they compare? The Coca-Cola Co K trades at $86.32 (market cap $372.08B), while Moderna, Inc. trades at $60.53 (market cap $24.18B). The key difference: The Coca-Cola Co K is far larger — about 15.4× Moderna, Inc.'s market cap, and The Coca-Cola Co K pays a 2.45% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

KOMRNA
Market Cap
$372.08B$24.18B
Volume
14,630,257
Sector
Consumer StaplesHealth
52-Week High
$89.08$81.80
52-Week Low
$65.67$22.36
Enterprise Value
$399.26B$20.33B
Dividend Yield
2.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Coca-Cola Co K

Coca-Cola (KO) trades at $86.87, down 0.21% on the day, with a bullish technical signal and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $0.97 exceeding the $0.92 forecast. Key valuation ratios include a P/E of 26.09 and ROE of 44.23%, while cash flow trends show robust operational performance. Recent news highlights institutional buying and stable demand trends ahead of Q3 earnings.

The outlook remains positive with a consensus price target of $95.83, implying 10.3% upside. Strengths include a 64-year dividend growth streak and high profitability, but risks involve regional demand divergence and elevated debt levels. Analyst sentiment is bullish with 60% buy ratings, supporting a favorable investment case for long-term holders.

Moderna, Inc.

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About The Coca-Cola Co K

The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.

Read more on KO

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA